This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

LIVE Online Course Running June 4 & 6 and June 18 & 20
10am-2pm EDT

LIVE Online Course Running June 4 & 6 and June 18 & 20
10am-2pm EDT

Understand Current and Emerging Expectations for CMC Analytical Studies to Align with Regulators and Expedite the Development of All Type of Biological Products

Critical-Path Analytical Studies for Accelerated, Breakthrough and Biosimilar Products

Introductory Level CMC Analytical Studies and Lab Quality Practices

Dear Attendee,

We look forward to welcoming you to the upcoming Introductory CMC Analytical Studies and Lap Quality Practices live online training course.

While the course was originally scheduled for June 3-4 & 6-7, the instructor will now deliver the course on the following dates:

  • June 4th (Tuesday)
  • June 6th (Thursday)
  • June 18th (Tuesday)
  • June 20th (Thursday)

Each of these four days will still run daily from 10am-2pm EDT. We will also be recording all 4 daily sessions for our attendees to watch on-demand.

Course Overview

This course will provide attendees with a concise but comprehensive overview of all relevant regulatory, technical, and quality elements necessary to assure successful planning and documentation of the required CMC analytical and stability studies for biological products. Key data deliverables from each phase of development will be illustrated. Current ‘hot-button’ CMC analytical and stability issues will be presented, and strategies for preventing (or remediating) gaps will be presented, based on real-world experiences of Dr. Nadine Ritter supporting hundreds of biological products over more than 25 years.

What will you learn?

Phase-specific requirements

Gain a comprehensive overview of the current and emerging regulatory guidances that govern the phase-specific requirements for CMC analytical studies with any type of biological product

Critical path studies

See the rationale behind the critical path analytical CMC studies required throughout different stages of the product life cycle including pre-clinical, clinical trials, commercialization, and post-approval to make effective timeline decisions

Product specifications

Understand the rationale behind setting meaningful, supportable product specifications; learn the key elements to include in biological product analytical control strategies

Method lifecycles

Review the applicable regulations that define phase-specific method validation expectations, and learn best practices for analytical method qualification, validation, verification, tech transfer, and method bridging for all types of methods for biological products.

R&D to GxP Quality Practices

Understand the specific laboratory operational requirements for GxP compliance during product development, and learn the emerging expectations for lab quality and data integrity in R&D labs that generate the CMC data submitted in product dossiers

Live Online Academies

Gain real-time access to a subject matter expert delivering online training in a structured virtual classroom environment. Live online academies are virtual versions of some of our most popular face-to-face courses.

Over 4 days students will learn through:

  • Direct interaction with the trainer during live sessions
  • Participation in interactive features within sessions including polls, Q&A, break out rooms, tasks, case studies, and more
  • Interaction with peers during live sessions and through the online forum

Timings and dates are subject to change - final confirmation will be provided with login details. Delegates will receive login instructions within a week of the course start date. If you have any questions please contact

Who is this course for?

This training course is intended for professionals who are involved with stability testing for biotechnology products, directly or indirectly. Professionals from Pharmaceutical, Biotechnology, Drug Delivery and Medical Device companies should attend, such as, but not limited to:

  •  Stability Directors/ Supervisors/Managers/Analysts/Coordinators
  • Laboratory Supervisors/ Managers
  • Project Managers/Coordinators
  • Quality Control Analytical Chemists
  • Research and Development Chemists
  • Biostatisticians
  • LIMS Administrators
  • QA/QC Reviewers
  • Validation Scientists
  • Calibration/Metrology Groups
  • Internal or Independent Auditors
  • Manufacturing/Production Managers

The Analytical Side of CMC with Course Leader, Nadine Ritter

Nadine Ritter, President and Analytical Advisor at Global Biotech Experts, discusses how shortening timelines are impacting the analytical side of chemistry, manufacturing, and control (CMC).

Analytical Development


Rottapharm Biotech

Nadine was really clear, it is evident that she really knows the object of this course. By using examples, she made everything really easy to understand.